Colorectal cancer

Victor Moreno Aguado / Ramon Salazar Soler

PRINCIPAL INVESTIGATORS
  • Mercedes Martinez Villacampa
  • Cristina Santos Vivas
  • Gemma Soler González
  • Eric Jeffrey Duell
CLINICAL RESEARCHERS
  • Antonio Soriano Izquierdo
  • Francisco Rodriguez Moranta
  • Ferran Losa Gaspa
  • Albert Sueiras Gil
  • Mireia Obon Santacana
  • Esther Kreisler Moreno
  • Jose Carlos Ruffinelli Rodriguez
  • Domenico Nicola Fraccalvieri
POSTDOCTORAL RESEARCHERS
  • Jose Marcos Moreno Cabrera
  • Marisa Martinez Muñoz
  • Alba Magallon Baro
  • Elies Ramon Gurrea
  • Gemma Ibañez Sanz
  • Nuria Moragas Garcia
  • Miguel Socolovsky Visiedo
  • Francisco David Moron Duran
  • Claudia Monica Aura Gonzalez
  • David Bars Cortina
  • Ditsuhi Iskandaryan
PREDOCTORAL RESEARCHERS
  • Blanca Rius Sansalvador
  • Lois Riobo Mayo
SCIENTIFIC SUPPORT
  • Cristina Martinez Muñoz
  • Elisabet Guino Domenech
  • Susana Lopez Ruiz
  • Ferran Moratalla Navarro
  • Vanessa Tierraseca Matute
  • Carmen Rosa Atencia Rojas
  • Eduardo Delgado De La Iglesia
MANAGEMENT SUPPORT
  • Thiago Carnaval
  • Mario Amigo Garcia
  • Jordi Vea Barbany
  • Adelaida Piera Sancerni
  • Silvia Murcia Muñoz
  • Olga Lopez Ciercoles
  • Paula Ximena Fernandez Calotti
  • Camille Martine Marie Frey
  • Catalina Isabel Cofre Muñoz
Cancer
Oncobell

Scientific production

46

PAPERS

Average IF: 8,62

 

15

LED PAPERS

Average IF: 6,16

20 PUBLICATIONS IN FIRST DECILE

36 PUBLICATIONS IN FIRST QUARTILE

39 PUBLICATIONS IN OPEN ACCESS

Selected publications:

  • Carreras Torres,R;Galvan Femenia,I;Farre,X;Cortes,B;Diez Obrero,V;Carreras,A;Moratalla Navarro,F et al, Multiomic integration analysis identifies atherogenic metabolites mediating between novel immune genes and cardiovascular risk, Genome Med., 2024;16(1):122-122, doi:10.1186/s13073-024-01397-2
  • Laskar,RS;Qu,C;Huyghe,JR;Harrison,T;Hayes,RB;Cao,Y;Campbell,PT et al, Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer, Ann. Oncol., 2024;35(6):523-536, doi:10.1016/j.annonc.2024.02.008
  • Moreno Cabrera,JM;Feliubadaló,L;Pineda,M;Prada Dacasa,P;Ramos Muntada,M;Del Valle,J;Brunet,J et al, SpadaHC: a database to improve the classification of variants in hereditary cancer genes in the Spanish population, Database, 2024;2024doi:10.1093/database/baae055
  • Obón Santacana,M;Moratalla Navarro,F;Guinó,E;Carreras Torres,R;Díez Obrero,V;Bars Cortina,D;Ibáñez Sanz,G et al, Diet Impacts on Gene Expression in Healthy Colon Tissue: Insights from the BarcUVa-Seq Study, Nutrients, 2024;16(18):doi:10.3390/nu16183131
  • Ramon,E;Obón Santacana,M;Khannous Lleiffe,O;Saus,E;Gabaldón,T;Guinó,E;Bars Cortina,D et al, Performance of a Shotgun Prediction Model for Colorectal Cancer When Using 16S rRNA Sequencing Data, Int J Mol Sci, 2024;25(2):doi:10.3390/ijms25021181

Research highlights

PROJECTS

3 Granted competitive projects
23 Ongoing competitive projects

6 Started clinical trials
48 Ongoing clinical trials

PUBLISHED WORKS

5 Clinical guidelines

NETWORKS

SGR GRC
ECPC
AGAUR SGR GRC-2021
CIBERESP
GECCO
UNCAN
CA21116

 

Selected projects

  • PID2023-151570OB-I00. Herencia epigenética intergeneracional en humanos: determinantes y contribución a la heredabilidad desconocida y al riesgo del cáncer colorrectal. Ministerio de Ciencia e Innovación. Budget: 337.500€. 2024-2028. PI: MORENO AGUADO, VICTOR RAUL.
  • TRNSC213877MORE/AC22/00021. TANGERINE: Artificial-intelligence-based end-to-end prediction of cancer immunotherapy response. Instituto de Salud Carlos III (ISCIII)/Asociación Española Contra el Cáncer (AECC). Budget: 296.341€. 2022-2026. PI: MORENO AGUADO, VICTOR RAUL.
  • AC21_2/00013 // PERME212445MORE. IMAGene: Epigenomic and machine learning models to predict pancreatic cancer: development of a new algorithm to integrate clinical, omics, DNA methylation biomarkers and environmental data for early detection of pancreatic cancer in high-risk individuals. Instituto de Salud Carlos III (ISCIII)/Asociación Española Contra el Cáncer (AECC). Budget: 304.687,96€. 2022-2025. PI: MORENO AGUADO, VICTOR RAUL.
  • FORT23/00032. Smart Health Community (SHC), promoviendo la medicina basada en el valor. Instituto de Salud Carlos III. Budget: 416.724€. 2024-2027. PI: MORENO AGUADO, VICTOR RAUL.
  • GCTRA18022MORE. Genetic and metabolomics screening towards the precision medicine in cancer prevention. Asociación Española Contra el Cáncer (AECC). Budget: 500.000€. 2018-2024. PI: MORENO AGUADO, VICTOR RAUL.